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Abstract
Background: Determination of the plasma concentrations of arginine and other amino acids is
important for understanding pathophysiology, immunopathology and nutritional supplementation
in human disease. Delays in processing of blood samples cause a change in amino acid
concentrations, but this has not been precisely quantified. We aimed to describe the concentration
time profile of twenty-two amino acids in blood from healthy volunteers, stored at room
temperature or on ice.
Methods: Venous blood was taken from six healthy volunteers and stored at room temperature
or in an ice slurry. Plasma was separated at six time points over 24 hours and amino acid levels
were determined by high-performance liquid chromatography.
Results: Median plasma arginine concentrations decreased rapidly at room temperature, with a
6% decrease at 30 minutes, 25% decrease at 2 hours and 43% decrease at 24 hours. Plasma
ornithine increased exponentially over the same period. Plasma arginine was stable in blood stored
on ice, with a < 10% change over 24 hours. Plasma taurine increased by 100% over 24 hours, and
this change was not prevented by ice. Most other amino acids increased over time at room
temperature but not on ice.
Conclusion: Plasma arginine concentrations in stored blood fall rapidly at room temperature, but
remain stable on ice for at least 24 hours. Blood samples taken for the determination of plasma
amino acid concentrations either should be placed immediately on ice or processed within 30
minutes of collection.
Background
Quantification of plasma amino acids is not routinely
offered by clinical laboratories and thus plasma often
needs to be transported to research or reference laborato-
ries for testing. In order to accurately assess the concentra-
tion of plasma amino acids, it is important to know their
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stability in human blood which has been stored or trans-
ported prior to testing. Previous studies addressing this
question have been small and the rate of degradation has
not been precisely quantified.
Arginine, the precursor of nitric oxide (NO) [1], is impor-
tant for endothelial [2] and immunological [3] function
and is acutely decreased in sepsis [4,5], malaria [6] and
trauma [7], and was thus the focus of this study. The
major routes for arginine metabolism in humans are
metabolism by arginase to urea and ornithine; use for cre-
atine synthesis; and metabolism by nitric oxide synthase
to NO and citrulline [8]. Both red blood cells (RBCs) [9]
and macrophages [10] are rich in arginase. In stored
packed RBCs, arginase is released and the resulting degra-
dation of plasma arginine is thought to be a mechanism
of transfusion-associated immunosuppression [9,11].
Other amino acids which are commonly added to supple-
mentary nutrition for critically ill patients may also play
an important role in immune function including tryp-
tophan [12] glutamine [13] and taurine [14,15].
Hainque and colleagues studied eight healthy volunteers
and found a "significant degradation" of plasma arginine
following 4 hours at room temperature but this was not
quantified and no other time points were reported [16].
Schaefer et al. studied one volunteer and found a 50%
decrease in plasma arginine after 6 hours at room temper-
ature compared with a 10% decrease after 6 hours at 4
degrees centigrade, with earlier time points not reported
[17]. Nutall and colleagues reported time profile data
from one volunteer, which showed an approximate 33%
decrease in plasma arginine by 2 hours at room tempera-
ture [18].
To determine the impact of delayed processing we under-
took a study to estimate the rate of arginine degradation
in human plasma at room temperature and on ice. We
hypothesised that this degradation would be primarily
due to plasma arginase activity and that there would be
less than 10% degradation at 2 hours in samples placed
immediately on ice. We also sought to determine the
effect of delayed separation and freezing of plasma on the
concentration of other amino acids.
Methods
The study was considered by the Chair of the Human
Research Ethics Committee of the Menzies School of
Health Research and Northern Territory Department of
Health and Families, and was approved as a laboratory
quality assurance activity which did not require full ethi-
cal review. Following written informed consent, six
healthy normotensive fasting volunteers had venous
blood collected into 12 × 2 mL lithium heparin tubes
(Vacutainer, Becton Dickinson, Franklin Lakes, New Jer-
sey) using a 21 gauge needle and vacutainer system. For
each subject, the first six tubes were immediately placed
into an ice slurry and the second six were left at room tem-
perature (25° Celsius (C)) in an air conditioned labora-
tory. After intervals of 0 minutes, 30 minutes, 2 hours, 4
hours, 8 hours and 24 hours from the time of venepunc-
ture, the tubes were centrifuged at 3000 rpm for 10 min-
utes (either at 4°C or at room temperature as appropriate)
and the plasma immediately separated and stored at -
80°C.
Subsequently, following thawing, plasma amino acids
were extracted with ethanol, then derivatized with AccQ-
Fluor (Waters, Milford, MA). Amino acid concentrations
were then determined by reverse-phase high performance
liquid chromatography (HPLC; Shimadzu corporation,
Kyoto, Japan) with UV (250 nm) and fluorescence (exci-
tation 250 nm, emission 395 nm) detection, using a
method modified from van Wandelen and Cohen [19].
The data were analysed using Stata 10 (Statacorp, College
Station, Texas) and GraphPad Prism 5 (Graphpad soft-
ware, San Diego, California). Due to the small number of
subjects, data were summarized using median and inter-
quartile range. Median amino acid concentrations over
time were compared using a paired Wilcoxon test, with a
p-value of < 0.05 considered significant. The arginine deg-
radation curve was fitted using a one-phase exponential
decay model. The sample size was determined using data
from an earlier experiment (unpublished data), which
found that there was 31.8% (std dev = 14%) degradation
of arginine at room temperature by 2 hours. Using a
power of 80% and a significance level of 5%, five subjects
in each group would be needed to detect a difference of
22% degradation at 2 hours, meaning less than 10% deg-
radation in the ice group. To allow for sample wastage and
errors, we recruited six subjects.
Results
Of the six study subjects, half were male, and the median
age was 37.5 years, with a range of 19-47 years (table 1).
All were healthy, of normal weight and normotensive,
and none had cardiovascular disease or diabetes mellitus.
The median baseline plasma arginine concentration was
74.9 μmol/L, similar to previously reported mean plasma
arginine concentrations from healthy volunteers, the
majority of which are between 60 and 80 μmol/L [20].
Arginine and ornithine time profiles at room temperature
Plasma arginine concentration decreased rapidly at room
temperature (Figures 1a, 2, Table 2) with 6% degradation
within 30 minutes, 25% degradation within 2 hours and
43% degradation within 24 hours. A non-linear model of
the plasma arginine profile over time was defined by the
equation Y = ((Y0-P)*e-kt)+P, where t = time in hours, P =BMC Clinical Pathology 2009, 9:10 http://www.biomedcentral.com/1472-6890/9/10
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the plateau value, Y0 = initial value. The parameters of the
model were Y0 = 81.3, P = 37.8, and k = 0.6273. This
model fitted the data well, with an R2 of 0.73. Plasma
ornithine concentration increased exponentially at room
temperature (Table 1, Figure 2), with a 4% increase at 30
minutes, a 62% increase at 2 hours, and a 183% increase
at 24 hours.
Arginine time profile on ice compared with room 
temperature
Plasma arginine was very stable on ice, with a less than
10% change over a 24 hour period. At 2 hours, the median
plasma arginine concentration had decreased by 6% in
the ice specimens compared with 25% in the room tem-
perature specimens (p < 0.001) (Figure 1). At 24 hours,
the change in arginine was negligible for the ice specimens
compared with a 43% decrease at room temperature (p <
0.001). Ornithine was also more stable on ice, with a 24%
increase over the 24 hour period, compared with a 183%
increase at room temperature.
Time profile of other amino acids
For the majority of other amino acids, concentrations
increased by > 10% over 24 hours at room temperature
(Table 3). The majority of these changes were largely or
completely prevented in the blood that was placed on ice.
The most notable room temperature concentration
increases at 24 hours were seen with taurine (which dou-
bled) and glutamate (which increased more than five-
fold). The change in taurine was unusual in that it was
more marked in the blood placed on ice (a 126%
increase) than the room temperature specimens (a 100%
increase), suggesting that the increase in taurine may be
due to release from lysed cells rather than to an enzymatic
Table 1: Characteristics of study subjects
Subject Age (years) Gender Ethnicity
1 36 F Caucasian
2 39 M Caucasian
3 47 F Caucasian
4 27 F Caucasian
5 19 M Caucasian
6 44 M Caucasian
Plasma arginine time profile at room temperature and on ice Figure 1
Plasma arginine time profile at room temperature 
and on ice. Each curve represents an individual subject. Fig-
ure 1a depicts results from whole blood stored at room tem-
perature (25°C). Figure 1b depicts results from aliquots of 
the same blood samples which were stored in an ice slurry.
Time profile of median plasma arginine and ornithine concen- trations in blood stored at room temperature Figure 2
Time profile of median plasma arginine and ornithine 
concentrations in blood stored at room temperature. 
Each point represents the median value for that time, and the 
error bars represent the interquartile range. Median plasma 
arginine is indicated by triangles, and ornithine by solid cir-
cles.BMC Clinical Pathology 2009, 9:10 http://www.biomedcentral.com/1472-6890/9/10
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process (Figure 3). Tryptophan was very stable both at
room temperature and on ice.
Discussion
Plasma arginine concentration decreases rapidly in whole
blood held at room temperature, and this decrease is
greatly attenuated by placing the blood on ice. Ornithine,
the metabolic product of arginine metabolism by argin-
ase, rises exponentially at room temperature, and this rise
does not occur on ice, suggesting that it is due to an enzy-
matic process. Thus, it is likely that arginase is the primary
mechanism of arginine degradation in ex-vivo blood sam-
ples. This arginase could come from either lysed RBCs or
lysed leucocytes, but we did not evaluate the source of
arginase, and thus cannot determine which of these was
more important. In-vitro hemolysis is difficult to meas-
ure, as the released cell-free haemoglobin is immediately
bound by haptoglobin. While we have not proven this
hypothesis, our observations strongly suggest it.
Most other amino acids increase at room temperature but
not on ice, which also implies an enzymatic reaction.
Tryptophan is very stable both at room temperature and
on ice. Taurine and glutamine are unusual, in that they
increase markedly both at room temperature and on ice;
this may be due to cellular release rather than enzymatic
catabolism.
The rate of decrease of plasma arginine which we found in
blood held at room temperature is similar to that found
by Nuttall and colleagues in the only published paper to
have reported plasma arginine concentrations at room
temperature at more than two time points [18]. The lack
of early time points in other papers makes it difficult to
estimate the rate of decline and whether it is linear or
exponential. Nuttall et al. reported data in graphical form,
from a single subject up to 2.5 hours post venepuncture.
They found a fall from 89 μmol/L to approximately 60
μmol/L at 2 hours (a 33% drop), similar to our reported
decrease of 25% at 2 hours.
The large increases seen in taurine and glutamate in our
study have not previously been reported. Sahai et al.
measured amino acid levels in whole blood from twenty-
two volunteers, stored on ice for 1 hour or 2 hours, and
found a less than 10% decrease in plasma taurine and
glutamate at 1 and 2 hours [21]. Shaeffer et al. reported a
Table 2: Median (IQR) arginine and ornithine plasma concentrations over time from blood stored at room temperature compared 
with stored on ice
Baseline 30 minutes 2 hours 4 hours 8 hours 24 hours
Arginine RTa 74.9 70.3 49.6 40.4 37.3 42.6
73.2-87.8 63.4-75.5 46.0-53.6 35.8-45.8 32.1-42.6 25.5-42.8
Arginine Ice 79.6 77.1 74.8 78.6 80.4 81.0
76.8-93.0 74.6-90.8 73.4-86.9 74.6-86.1 79.4-86.7 79.9-83.0
Ornithine RT 44.7 45.6 72.6 87.4 101.6 114.1
32.9-60.8 39.5-69.8 58.7-94.2 69.1-112.3 79.4-125.9 100.9-153.6
Ornithine Ice 38.6 31.6 39.2 40.5 36.3 43.1
29.4-57.3 38.3-59.2 30.2-60.0 30.5-61.9 32.8-61.5 36.2-68.1
a. RT = Room Temperature
Time profile of median plasma taurine concentrations in  blood stored at room temperature and on ice Figure 3
Time profile of median plasma taurine concentra-
tions in blood stored at room temperature and on 
ice. Each point represents the median value for that time, 
and the error bars represent the interquartile range. Median 
plasma taurine at room temperature is represented by solid 
circles, and median plasma taurine on ice is represented by 
triangles.BMC Clinical Pathology 2009, 9:10 http://www.biomedcentral.com/1472-6890/9/10
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Table 3: Change in amino acid concentrations in whole blood after 24 hours at room temperature and on ice.
% Change at 24 h at RTa, b % Change at 24 h on iceb
Group 1 - ≤ 10% change at RTa over 24 h
Citrulline -4 (-6, 4) -7 (-9, -4)
Glutamine -10 (-13, -10) -5 (-5, -4)
Hydroxyproline 8 (7,9) -3 (-4,-3)
Methionine 0 (-2, 1) 1 (1, 6)
Tryptophan 7 (5, 8) 4 (4, 6)
Tyrosine 8 (5, 12) -2 (-3, -1)
Valine 8 (4, 11) 1 (0, 1)
Group 2 - > 10% increase at RTa over 24 h
Alanine 18 (16,20) 0 (-1, 0)
Asparagine 17 (12, 21) 0 (-1, +3)
Glutamate 593 (563, 612) 38 (92, 186)
Glycine 26 (24, 34) 3 (2, 4)
Histidine 23 (17, 27) 1 (0, 1)
Isoleucine 16 (10, 21) 0 (-1, 2)
Leucine 23 (17, 34) 2 (1, 5)
Lysine 19 (18, 19) 2 (1, 5)
Ornithine 183 (180, 224) 24 (23,25)
Phenylalanine 15 (14,22) 1 (1, 3)
Proline 11 (6,13) 1 (-1,2)
Serine 18 (17,28) 6 (2,6)
Taurine 100 (94, 102) 126 (120, 147)
Threonine 11 (10, 14) -2 (-5, 0)
Group 3 - > 10% decrease at RTa over 24 h
Arginine -43 (-65, -43) -1 (-5, 4)
a. RT - Room temperature
b. Expressed as median % change (Interquartile range)
Note - % change values are an increase (positive change) unless otherwise specified.BMC Clinical Pathology 2009, 9:10 http://www.biomedcentral.com/1472-6890/9/10
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< 10% decrease in plasma taurine and glutamate at 6
hours in blood held at room temperature from one
healthy volunteer [17]. The reason for this discrepancy is
unclear. Both papers used different methods for amino
acid quantification than we did. Sahai et al did not meas-
ure time points beyond 2 hours, and most of the increase
in both taurine and glutamine in our study occurred
beyond 2 hours. However, until this finding is reproduced
by other investigators, it should be regarded with caution.
The primary limitations of this study are the relatively
small number of subjects and the lack of subjects suffering
from sepsis, trauma or other conditions of interest. A
larger number of subjects would allow a more accurate
estimate of the time profile of arginine degradation over
time. Considering arginase activity is increased in severe
sepsis [22] and trauma [23], it is unclear if blood from
patients with these conditions would yield the same
results as we observed. We did not directly measure argin-
ase activity in blood or plasma, and thus our inference
that plasma arginase is primarily responsible for the
observed ex-vivo arginine degradation is based on indirect
evidence. However, the only other significant mechanism
for arginine degradation likely to occur ex-vivo is the
breakdown of arginine to NO and citrulline by nitric
oxide synthase, which accounts for less than 5% of
arginine metabolism in healthy humans [24].
One potential implication of these data is that whole
blood stored for the purpose of transfusion is likely to
contain non-physiological concentrations of amino acids,
which may have unintended immunosuppressive effects.
These data also reinforce the importance of accurate meth-
odological descriptions in papers reporting plasma amino
acid levels. In a hospital setting, it is not always possible
to process samples within 30 minutes of collection. It is
therefore essential to note the time between collection
and freezing when reporting concentrations of plasma
amino acids. This is particularly important if the sample
cannot be kept on ice - for example, if the blood is to be
used for both peripheral blood mononuclear cell (PBMC)
collection and amino acid analysis. As PBMCs are dam-
aged by freezing, these samples must be kept at room tem-
perature and processed as soon as possible to allow
accurate analysis of both PBMC function and amino acid
concentrations. Furthermore, where plasma amino acids
are being measured for clinical applications, our data
emphasise the importance of timely separation and freez-
ing of plasma to avoid potential diagnostic errors.
Conclusion
In conclusion, arginine undergoes rapid ex-vivo degrada-
tion at room temperature but this does not occur on ice;
plasma tryptophan is stable for at least 24 hours both at
room temperature and on ice; plasma taurine concentra-
tions show large increases both at room temperature and
on ice. Blood collected for the purposes of plasma amino
acid determination should be placed immediately on ice;
if this is not possible, plasma should be frozen with 30
minutes of collection.
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